[ad_1] Results of the Pivotal Phase 3 PROSPER Study, Which Evaluated Treatment with Astellas Pharma Enzalutamide with Androgen deprivation (Adt) Compared to Placebo More Adt in Patients With Prostate Cancer non-metastatic castration-resistant …
Read More »Study Results Pivotalsul Crpc Prostate Tumor
